Catheter Precision Inc (VTAK)
0.426
+0.01
(+1.43%)
USD |
NYAM |
Nov 21, 16:00
0.415
-0.01
(-2.58%)
After-Hours: 20:00
Catheter Precision Enterprise Value: 3.843M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.843M |
| November 19, 2024 | 3.997M |
| November 18, 2024 | 3.910M |
| November 15, 2024 | 4.243M |
| November 14, 2024 | 4.483M |
| November 13, 2024 | 4.324M |
| November 12, 2024 | 3.960M |
| November 11, 2024 | 4.164M |
| November 08, 2024 | 4.302M |
| November 07, 2024 | 4.403M |
| November 06, 2024 | 4.245M |
| November 05, 2024 | 4.412M |
| November 04, 2024 | 4.563M |
| November 01, 2024 | 4.547M |
| October 31, 2024 | 4.392M |
| October 30, 2024 | 4.563M |
| October 29, 2024 | 4.888M |
| October 28, 2024 | 2.421M |
| October 25, 2024 | 2.622M |
| October 24, 2024 | 3.504M |
| October 23, 2024 | 3.222M |
| October 22, 2024 | 3.623M |
| October 21, 2024 | 3.640M |
| October 18, 2024 | 3.623M |
| October 17, 2024 | 2.003M |
| Date | Value |
|---|---|
| October 16, 2024 | 1.969M |
| October 15, 2024 | 1.769M |
| October 14, 2024 | 1.689M |
| October 11, 2024 | 1.689M |
| October 10, 2024 | 1.706M |
| October 09, 2024 | 1.605M |
| October 08, 2024 | 1.616M |
| October 07, 2024 | 1.639M |
| October 04, 2024 | 1.728M |
| October 03, 2024 | 1.728M |
| October 02, 2024 | 1.743M |
| October 01, 2024 | 1.821M |
| September 30, 2024 | 1.845M |
| September 27, 2024 | 1.844M |
| September 26, 2024 | 1.828M |
| September 25, 2024 | 1.946M |
| September 24, 2024 | 2.128M |
| September 23, 2024 | 1.921M |
| September 20, 2024 | 1.896M |
| September 19, 2024 | 1.938M |
| September 18, 2024 | 1.890M |
| September 17, 2024 | 1.864M |
| September 16, 2024 | 1.896M |
| September 13, 2024 | 1.839M |
| September 12, 2024 | 1.823M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.63M
Minimum
Dec 17 2019
5.064M
Maximum
Jun 30 2024
-13.61M
Average
-13.95M
Median
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 5.521M |
| Perspective Therapeutics Inc | 150.86M |
| Retractable Technologies Inc | -17.60M |
| InfuSystems Holdings Inc | 219.39M |
| Xtant Medical Holdings Inc | 85.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.12M |
| Revenue (Quarterly) | 0.096M |
| Total Expenses (Quarterly) | 2.955M |
| EPS Diluted (Quarterly) | -2.01 |
| Gross Profit Margin (Quarterly) | 89.58% |
| Profit Margin (Quarterly) | -4.29K% |
| Earnings Yield | 211.5% |
| Normalized Earnings Yield | 211.54 |